222 related articles for article (PubMed ID: 26895101)
1. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.
Beaulieu JF; Herring E; Kanaoka S; Tremblay É
Oncotarget; 2016 Mar; 7(12):14684-92. PubMed ID: 26895101
[TBL] [Abstract][Full Text] [Related]
2. Droplet digital PCR for quantification of
Herring E; Kanaoka S; Tremblay É; Beaulieu JF
World J Gastroenterol; 2017 Apr; 23(16):2891-2898. PubMed ID: 28522907
[TBL] [Abstract][Full Text] [Related]
3. A Stool Multitarget mRNA Assay for the Detection of Colorectal Neoplasms.
Herring E; Kanaoka S; Tremblay E; Beaulieu JF
Methods Mol Biol; 2018; 1765():217-227. PubMed ID: 29589311
[TBL] [Abstract][Full Text] [Related]
4. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
5. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
6. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
7. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
[TBL] [Abstract][Full Text] [Related]
8. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
9. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
[TBL] [Abstract][Full Text] [Related]
10. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer.
Tao S; Seiler CM; Ronellenfitsch U; Brenner H
Acta Oncol; 2013 Nov; 52(8):1667-75. PubMed ID: 23617541
[TBL] [Abstract][Full Text] [Related]
12. Direct serum assay for cell-free bmi-1 mRNA and its potential diagnostic and prognostic value for colorectal cancer.
Zhang X; Yang X; Zhang Y; Liu X; Zheng G; Yang Y; Wang L; Du L; Wang C
Clin Cancer Res; 2015 Mar; 21(5):1225-33. PubMed ID: 25547677
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
[TBL] [Abstract][Full Text] [Related]
14. A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection.
Kalimutho M; Del Vecchio Blanco G; Cretella M; Mannisi E; Sileri P; Formosa A; Pallone F; Federici G; Bernardini S
Int J Colorectal Dis; 2011 May; 26(5):583-92. PubMed ID: 21225430
[TBL] [Abstract][Full Text] [Related]
15. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.
Tagore KS; Lawson MJ; Yucaitis JA; Gage R; Orr T; Shuber AP; Ross ME
Clin Colorectal Cancer; 2003 May; 3(1):47-53. PubMed ID: 12777192
[TBL] [Abstract][Full Text] [Related]
18. Stool DNA Integrity Method for Colorectal Cancer Detection.
Rengucci C; De Maio G; Menghi M; Calistri D
Methods Mol Biol; 2018; 1765():193-202. PubMed ID: 29589309
[TBL] [Abstract][Full Text] [Related]
19. Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers.
Wu CW; Cao X; Berger CK; Foote PH; Mahoney DW; Simonson JA; Anderson BW; Yab TC; Taylor WR; Boardman LA; Kisiel JB; Ahlquist DA
Dig Dis Sci; 2017 Aug; 62(8):1985-1994. PubMed ID: 28660489
[TBL] [Abstract][Full Text] [Related]
20. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]